Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Multiple myeloma.

× No keyword cloud information.

30 in total

1. Elderly man with a pulmonary mass and osteolytic lesions: is it primary pulmonary plasmacytoma or multiple myeloma with an extramedullary pulmonary nodule?

Authors: Aung Myint Tun; Yu Yu Thar; Aye Min Soe; Ei Ei Naing
Journal: BMJ Case Rep Date: 2016-06-29

2. Multiple myeloma with 1q21 amplification is highly sensitive to MCL-1 targeting.

Authors: Anne Slomp; Laura M Moesbergen; Jia-Nan Gong; Marta Cuenca; Peter A von dem Borne; Pieter Sonneveld; David C S Huang; Monique C Minnema; Victor Peperzak
Journal: Blood Adv Date: 2019-12-23

3. Development of a conceptual model to illustrate the impact of multiple myeloma and its treatment on health-related quality of life.

Authors: R Baz; H M Lin; A-M Hui; R D Harvey; K Colson; K Gallop; P Swinburn; J Laubach; D Berg; P Richardson
Journal: Support Care Cancer Date: 2015-02-24 Impact factor: 3.603

Review 4. [Diagnostic molecular pathology of lymphatic and myeloid neoplasms].

Authors: W Klapper; H Kreipe
Journal: Pathologe Date: 2015-03 Impact factor: 1.011

5. Diffusion-weighted imaging (DWI) in diagnosis, staging, and treatment response assessment of multiple myeloma: a systematic review and meta-analysis.

Authors: Pooya Torkian; Bahar Mansoori; Jens Hillengass; Javid Azadbakht; Sina Rashedi; Sarah S Lee; Behrang Amini; Pietro Andrea Bonaffini; Majid Chalian
Journal: Skeletal Radiol Date: 2022-07-26 Impact factor: 2.128

6. Regulation of metastasis of pediatric multiple myeloma by MMP13.

Authors: Xiaoru Wang; Xiaocang Cao
Journal: Tumour Biol Date: 2014-05-29

7. Transmissible cytotoxicity of multiple myeloma cells by cord blood-derived NK cells is mediated by vesicle trafficking.

Authors: B Martin-Antonio; A Najjar; S N Robinson; C Chew; S Li; E Yvon; M W Thomas; I Mc Niece; R Orlowski; C Muñoz-Pinedo; C Bueno; P Menendez; C Fernández de Larrea; A Urbano-Ispizua; E J Shpall; N Shah
Journal: Cell Death Differ Date: 2014-08-29 Impact factor: 15.828

8. Using pharmacy management systems for research: survival outcomes for lenalidomide in multiple myeloma in the clinical setting.

Authors: Megan M Sharkey; Daniel McKavanagh; Euan Walpole; Peter Mollee; Samantha A Hollingworth
Journal: Int J Clin Pharm Date: 2017-06-01

9. A rare cause of severe hepatomegaly with an improving outcome.

Authors: Line Godskesen; Niels Abildgaard; Jens Kjeldsen; Aleksander Krag
Journal: BMJ Case Rep Date: 2014-04-03

10. A Phase I Study to Assess the Safety and Pharmacokinetics of Single-agent Lorvotuzumab Mertansine (IMGN901) in Patients with Relapsed and/or Refractory CD-56-positive Multiple Myeloma.

Authors: Sikander Ailawadhi; Kevin R Kelly; Robert A Vescio; Sundar Jagannath; Jeffrey Wolf; Mecide Gharibo; Taimur Sher; Leyla Bojanini; Maurice Kirby; Asher Chanan-Khan
Journal: Clin Lymphoma Myeloma Leuk Date: 2018-09-05